Haijie Han

Haijie Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haijie Han has a total of 144 co-authors. Here are the top co-authors by number of shared publications:

  • Ke Yao

    Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, China

    17 shared publications
  • Jian Ji

    MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, P. R. China

    10 shared publications
  • Yin Zhang

    Key Lab of Ophthalmology Eye Center of The Second Affiliated Hospital, & Liangzhu Laboratory, & Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China

    9 shared publications
  • Ke Yao

    Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases

    7 shared publications
  • Su Li

    Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, 310009, P. R. China

    6 shared publications
  • Zeen Lv

    Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, 310009, P. R. China

    6 shared publications

Latest Publications

  • Open Access

    Antioxidant and anti-senescence supramolecular complexes for managing dry eye diseases

    by Xiaohui Song, Jiayan Zhu, Rouye Wang, Yili Yao, Tinglian Zhou, Wenbin Dai, Xianglin He, Qiao Jin, Ke Yao, Haijie Han

    Dry eye disease (DED) is a common ocular disorder that severely impairs daily life. Oxidative stress has been identified as a key pathogenic factor driving cellular senescence and corneal epithelial damage in DED. Herein, we developed a biocompatible supramolecular complex based on the host-guest interaction of TEMPO-modified β-cyclodextrin (TCD) and puerarin (Pue), designated as P@TCD, for managing DED. The P@TCD could mitigate the ROS accumulation, reduce DNA damage, promote cell cycle progression, and attenuate cellular senescence in the corneal epithelium, thus preventing the further deterioration of DED. In two DED mouse models, P@TCD demonstrated favorable therapeutic efficacy by reversing corneal epithelial defects, alleviating conjunctival damage, and accelerating lacrimal gland recovery, thereby restoring tear film homeostasis, especially improving tear film stability with TBUT values of more than 5.3 s, compared to the DED models of less than 2.8 s, which is even more than the Cycloome® of 3.7 s. These results suggested the considerable potential of this dual ROS scavenging strategy for the effective treatment of DED.


  • Open Access

    Cornea‐Penetrating Nanodrug Co‐Delivering VEGF‐Silencing siRNA and Lutein for Treating Age‐Related Macular Degeneration

    by Yong Li, Fan Xiao, Ziwei Liu, Yin Zhang, Jinshi Yu, Yiquan Chen, Hongxian Pan, Ning Xu, Feiyin Sheng, Haijie Han, et al.

    Age‐related macular degeneration (AMD) is the leading cause of irreversible blindness among the elderly, driven by oxidative stress, chronic inflammation, and pathological choroidal neovascularization (CNV). Although intravitreal anti‐vascular endothelial growth factor (VEGF) therapies remain the current clinical standard, their invasive nature and requirement for long‐term repeated injections present substantial risks and patient burden, underscoring an urgent need for noninvasive therapeutic alternatives. Here, we develop a noninvasive, cornea‐penetrating nanodrug based on chitosan‐modified lipid‐polymer hybrid nanoparticles (LPNPs) for co‐delivery of lutein and VEGF‐silencing siRNA (Chi@Lu/si NPs) to treat AMD. The structurally stabilized nanoparticles overcome the intrinsic instability of siRNA and the poor solubility of lutein, while the chitosan coating confers strong mucoadhesion and transient modulation of epithelial tight junctions, enabling a 3.3‐fold enhancement in trans‐epithelial transport across the ocular surface. Once delivered to the posterior segment, lutein effectively scavenges excessive reactive oxygen species and suppresses inflammatory cascades, whereas siRNA‐VEGF achieves precise VEGF gene silencing, collectively interrupting the pathological cycle driving CNV progression. In a laser‐induced CNV mouse model, topical administration of Chi@Lu/si NPs twice daily exerted potent inhibitory effects on neovascularization, with therapeutic efficacy comparable to that of intravitreal bevacizumab, reducing CNV lesion thickness to 58.9% of pre‐treatment levels while maintaining excellent ocular biocompatibility.

  • A boronate-phenolic network nanoplatform carrying dimethyl itaconate for ameliorating neovascular age-related macular degeneration

    by Yufeng Xu, Mingyu Xu, Jiqiao Qie, Bo Yu, Xianglin He, Yifan Zhou, Li Zhang, Qiao Jin, Juan Ye, Haijie Han

  • Open Access

    Clinical features and intraocular lens material properties for posterior capsule opacification risk prediction

    by Xianglin He, Su Li, Zeen Lv, Haijie Han, Ke Yao

    Posterior Capsule Opacification (PCO) remains a prevalent long-term complication following surgery for cataract, the world's primary blinding disease, significantly compromising visual outcomes. Although intraocular lens (IOL) material is a recognized risk factor, large-scale datasets linking granular material properties with longitudinal clinical outcomes remain scarce. Here, we present a real-world dataset comprising clinical records from 16,970 patients (22,709 eyes) who underwent cataract surgery at the Eye Center of the Second Affiliated Hospital of Zhejiang University School of Medicine in China between January 2019 and December 2022, with follow-up extending to May 2025. The dataset integrates patient demographics, systemic and ocular comorbidities, and surgical parameters. Crucially, these clinical variables are augmented with detailed IOL physicochemical specifications, covering both macroscopic design features and constituent chemical monomers (e.g., HEMA, EA). All records were extracted from electronic health records, rigorously anonymized, and technically validated against established epidemiological patterns. This resource provides a foundation for investigating the multifactorial determinants of PCO, facilitating analyses ranging from clinical risk assessment to the evaluation of biomaterial biocompatibility.

  • Iron Homeostasis Restoration via Triple-Pool-Targeted Nanotherapy for Enhanced Amelioration of Age-Related Macular Degeneration

    by Yifan Zhou, Mingyu Xu, Yufeng Xu, An Shao, Wenyu Cui, Wenyue Shen, Yingcheng He, Zhichu Chen, Yin Zhang, Qi Miao, et al.

    Oxidative stress-induced retinal pigment epithelium (RPE) damage and ferroptosis are critical in retinal degenerative diseases, particularly in age-related macular degeneration (AMD)─a major cause of irreversible blindness. Current clinical AMD treatment is predominantly dependent on intravitreal anti-VEGF administration targeting only late-stage choroidal neovascularization (CNV), with limitations of incomplete response and adverse effects. Herein, a facile synthesis of Nuci@PAM-BR, which was designed by modification of antioxidant bilirubin to the surface and encapsulation of antiferroptosis nuciferine in the hydrophobic cavity of polyamidoamine dendrimers, was reported, thus achieving iron homeostasis restoration via triple-pool-targeted scavenging properties for eradicating CNV in AMD management. Our results demonstrated that Nuci@PAM-BR could significantly attenuate CNV by targeting the detrimental "triple pool" in damaged RPE cells, exhibiting excellent antioxidant and anti-inflammatory properties that contributed to its excellent antiangiogenic effect, achieving an over 80% reduction in leakage area and an over 85% decline in neovascular lesion. Such triple-pool-targeted nanotherapy offers a promising alternative and holds significant potential for the future clinical treatment of diverse fundus neovascularization diseases, including AMD.

  • Self-Cascading Copper-Based Nanoassemblies Trigger Bacterial Cuproptosis-Like Death and Promote Wound Healing for Diabetic Drug-Resistant Bacterial Infections

    by Tianji Feng, Wenjie Fan, Yin Zhang, Yuexin Yang, Xiaohui Song, Yueyang Zhong, Qiao Jin, Lidan Hu, Ke Yao, Haijie Han

    Diabetes mellitus leads to systemic immunosuppression, increasing susceptibility to persistent infections and elevating the risk of severe complications. Concurrently, multidrug-resistant (MDR) pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) further exacerbate therapeutic difficulties. To address this challenge, we engineered peroxidase (POD)-like nanoassemblies (DC/Cu) through the copper-coordinated self-assembly of ε-poly(L-lysine)-derived carbon dots (CDs) and anti-inflammatory agent diclofenac sodium (DS). These nanoassemblies integrate antibacterial, anti-inflammatory, and tissue-reparative functionalities for the treatment of MDR bacteria-induced diabetic infections. Cationic DC/Cu can selectively adhere to bacterial membranes, enabling microenvironment-responsive spatiotemporal drug release. The POD-like activity of CDs catalyzes the endogenous H2O2, inducing membrane lipid peroxidation and enhancing cell membrane permeability, which facilitates copper influx. This self-cascade induces lethal intracellular copper overload in MRSA, with transcriptomic profiling confirming Cu2+-mediated inhibition of Fe–S cluster proteins and disruption of the tricarboxylic acid cycle, leading to subsequent activation of cuproptosis-like death pathway. Simultaneously, the released DS mitigates the inflammatory response, while Cu2+ facilitates tissue regeneration. MRSA-infected diabetic foot ulcers and diabetic MRSA keratitis models validated DC/Cu’s multifunctional efficacy in bacterial eradication, inflammatory mitigation, and tissue regeneration. Collectively, these multifunctional nanoassemblies demonstrate a promising and effective approach for precision therapeutic intervention against MDR pathogen-aggravated diabetic complications.


  • Top Cited Papers
    Open Access

    Self-polymerized polyphenol-based platform for the management of dry eye pathogenesis

    by Zixin Wang, Zeen Lv, Yuxuan Ge, Ruiyang Xue, Fang Wu, Haijie Han, Yin Wang

    The management of ocular surface inflammation, particularly in conditions like dry eye disease (DED), remains challenging due to multiple pathogenic causes and ocular barriers. Traditional eye drops usually provide transient and partial symptom relief, necessitating combined therapies to break the vicious cycle of oxidative stress and inflammation. To surmount these limitations, a polyphenol-based eye drop is developed via the self-polymerization of rosmarinic acid in the presence of hyaluronic acid, followed by co-assembly with cerium ions to afford monodispersed RHC NPs. To enhance the ocular retention efficiency, thiol groups are further decorated on NPs (termed as s-RHC NPs). In two mouse models of DED, topical administration of s-RHC NPs leads to comprehensive relief of symptoms, including inflammatory response suppression, corneal epithelial defect repair, and tear secretion recovery. We envision that this work might facilitate the treatment of DED and inspire the design of polyphenol-based nanoparticles via a self-polymerization strategy.


  • Open Access

    Supercationic Poly(Hexamethylene Biguanide)‐Derived Carbon Dots for Combating Multidrug‐Resistant Bacterial Keratitis

    by Wenjie Fan, Tianji Feng, Hongxian Pan, Yin Zhang, Zhebin Chen, Qiao Jin, Haijie Han, Jian Ji, Ke Yao

    Bacterial keratitis induced by multidrug‐resistant (MDR) bacteria is a formidable challenge, posing a significant threat to public vision. The compromised therapeutic efficiency against MDR bacteria and the risk of bacterial evolution due to excessive antibiotic usage necessitate the synthesis of novel antibacterial agents to combat MDR bacterial keratitis. In this study, we developed supercationic poly(hexamethylene biguanide)‐based carbon dots (P‐CDs) via a direct pyrolysis method with broad‐spectrum antibacterial activity against both methicillin‐resistant Staphylococcus aureus (MRSA) and multidrug‐resistant Pseudomonas aeruginosa (MRPA). The bactericidal mechanism of P‐CDs towards MRSA involves bacterial cell membrane disruption, DNA binding, and energy metabolism interference. In murine models of MRSA‐ and MRPA‐induced keratitis, the P‐CDs significantly reduced bacterial burden and alleviated corneal inflammation, demonstrating enhanced therapeutic performance compared to the conventional antibiotic levofloxacin. Furthermore, the minimum cytotoxicity, negligible tissue and systemic toxicity illustrated the favorable biocompatibility of P‐CDs. In conclusion, the pronounced in vitro and in vivo antibacterial efficiency and the favorable biocompatibility highlight the translational potential of P‐CDs as prospective antibiotic alternatives in the management of MDR bacterial keratitis.


  • Open Access

    Surface modification of intraocular lenses with zwitterionic poly(carboxybetaine) for posterior capsular opacification prevention

    by Wei Wang, Jiqiao Qie, Jiayin Deng, Yuexin Yang, Haijie Han, Ke Yao

    Posterior capsular opacification (PCO) remains the most common long-term complication after cataract surgery, primarily caused by adhesion and proliferation of residual lens epithelial cells (LECs) on the intraocular lens (IOL) surface. Here, we report a zwitterionic carboxybetaine-coating strategy to endow IOLs with anti-adhesive and anti-fibrotic properties without compromising optical clarity. The zwitterionic monomer carboxybetaine methacrylate (CBMA) was grafted onto the IOL surface via plasma activation, forming a stable antifouling interface. The CBMA-coated surface exhibited reduced water contact angle and smooth, uniform morphology while preserving optical transparency. Both anti-adhesion assays and IOL implantation studies confirmed that the highly antifouling CBMA coating markedly inhibited LEC adhesion, suppressed PCO formation, and maintained excellent biocompatibility. This work establishes a surface modification approach that integrates zwitterionic chemistry with clinical biomaterials, providing a promising pathway toward next-generation IOLs with intrinsic PCO-preventive functionality.

  • Open Access

    Cu2+-doped Hollow Ca2+-polyphenol nano-therapeutics for overcoming multidrug-resistant bacteria-induced infections

    by Yueyang Zhong, Wenjie Fan, Yue Huang, Rouye Wang, Tianji Feng, Mingzhi Su, Xiuming Jin, Qiao Jin, Ke Yao, Haijie Han

    The abuse of antibiotics has accelerated the emergence of multidrug-resistant (MDR) bacterial strains, while the development of novel antibiotics has faile